Dongsung Pharm (002210) — Cash Flow Quality Index

Latest as of March 2023: -1.00x

Dongsung Pharm (002210) has a Cash Flow Quality Index of -1.00x as of March 2023. Operating cash flow of ₩-771.02 Million is below net income of ₩771.59 Million, suggesting accrual-heavy earnings not yet converted to cash. Explore investment intensity of Dongsung Pharm to see how much of total assets are deployed in long-term investments.

Cash Flow Quality Index

-1.00x
Operating CF / Net Income

Operating Cash Flow

₩-771.02 Million
KRW

Net Income

₩771.59 Million
KRW

Data as of

Mar 2023
Most recent filing

Dongsung Pharm Cash Flow Quality Index (2008–2011)

Historical Cash Flow Quality Index for Dongsung Pharm across 3 annual periods. Values consistently above 1.0x indicate high-quality earnings. Check 002210 goodwill-adjusted equity ratio to evaluate the tangible quality of the company's equity base.

Annual Cash Flow Quality Index for Dongsung Pharm (2008–2011)

Year-by-year earnings quality comparison for Dongsung Pharm. For live market cap and the full company financial profile, see 002210 stock market capitalisation.

Year Quality Index Operating CF (KRW) Net Income YoY Change
2011 -1.55x ₩-2.64 Billion ₩1.70 Billion ▲ +82.4%
2009 -8.83x ₩-5.02 Billion ₩568.43 Million ▼ -8742.7%
2008 -0.10x ₩-365.26 Million ₩3.66 Billion
Cash Flow Quality Index = Operating Cash Flow / Net Income. Ratios above 1.0x indicate cash-backed earnings.